Download PDF
CC BY 4.0 · Rev Bras Ginecol Obstet 2021; 43(02): 148-149
DOI: 10.1055/s-0041-1725937
Letter to Editor

Management of Ectopic Pregnancy and the COVID-19 Pandemic

Rujittika Mungmunpuntipantip 
1   Ajeenkya DY Patil University, Pune, Maharashtra, India
,
Viroj Wiwanitkit 
1   Ajeenkya DY Patil University, Pune, Maharashtra, India
› Author Affiliations
› Further Information
   Permissions and Reprints

Dear Editor,

We would like to share ideas on the publication “Medical Treatment for Ectopic Pregnancy during the COVID-19 Pandemic.” Elito Júnior and Araujo Júnior[1] mentioned that the “clinical treatment of ectopic pregnancy by MTX or expectant management is an alternative during the COVID-19 pandemic. An early diagnosis and appropriate selection of treatment options are critical for the success of the treatment.”[1] In fact, using methotrexate (MTX) as alternative treatment for ectopic pregnancy during COVID-19 is a useful approach, and can reduce risk as well as decrease the workload at the hospital. The patient selection is very important. However, it should be noted that MTX might cause renal impairment,[2] and COVID-19 has a trend to develop renal impairment due to the immunopathological process of infection.[3] Close monitoring of the renal function is needed in MTX therapy, and the adjustment of the dosage based on renal function is important.[4]

Author's response



Publication History

Article published online:
26 February 2021

© 2021. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil